Organic Letters
Letter
in the reaction, with varying degrees of success. Reaction with
dimethylamine hydrochloride (or with the Eschenmoser salt)
did not produce isolable amounts of the β-amino diary-
ldienone, while the cyclic amines pyrrolidine (8%), piperidine
(30%), and piperazine (34%) gave reasonable yields. The
presence of electron-donating groups on the aryl rings is likely
to be detrimental to this reaction, because it may positively
contribute to isomerization and Nazarov type cyclization
leading to byproducts. In agreement with this fact, when the 4-
Cl substituent of compound 4 is replaced with a 4-methoxy
group, the isomerization reaction predominates, leading only
to the Z-β-amino diaryldienone (Z-SI-17, p S32) and the
corresponding Nazarov cyclized product. If the enone double
bond in compound 4 is not present, the reaction can be
conducted in DMF to reproducibly obtain the resultant β-
amino diarylenone 14 in yields up to 20%.
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
■
S
Experimental procedures and characterization for all new
compounds along with 1D and 2D NMR data (PDF)
Accession Codes
tallographic data for this paper. These data can be obtained
Cambridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: +44 1223 336033.
AUTHOR INFORMATION
Corresponding Authors
■
ORCID
confirmed the stereochemistry of the E and the Z isomers of 6.
However, neither isomer was amenable for X-ray crystallog-
raphy. Thus, we also studied the spectroscopic characteristics
and X-ray crystal data of several closely related systems and
summarized general trends between the stereochemistry of the
diaryl-substituted enone versus the NMR chemical shift of the
For compounds of structure 6, a characteristic downfield shift
is observed for this enone proton in the E-isomer than in the
Z-isomer. This may be due to a deshielding magnetic
anisotropic effect by the carbonyl group.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
This work was supported by the National Institutes of Health
(CA164331 and CA12861), the Prostate Cancer Foundation
(Challenge Award and VAlor Award), and the U.S. Depart-
ment of Veterans Affairs.
The β-amino diaryldienone compounds of structure E-6 that
we have synthesized through the chemistry outlined here have
shown excellent in vitro and in vivo antiprostate cancer activity
in androgen receptor (AR) positive tumors.8−10 Functionally,
they have shown potent activity as AR degraders and as
inhibitors of the AR transactivation domain.8 A complete
disclosure of the biological activity of these compounds will be
reported elsewhere. The β-amino enone functionality of E-6
can also undergo further synthetic transformations (Scheme 3)
to yield other compounds of medicinal chemistry interest.20
REFERENCES
■
̈
(1) Mannich, C.; Krosche, W. Ueber ein Kondensationsprodukt aus
Formaldehyd, Ammoniak und Antipyrin. Arch. Pharm. 1912, 250,
647−667.
(2) Blicke, F. F. The Mannich Reaction. Organic Reactions; John
Wiley and Sons, Inc.: 2011; pp 303−341.
(3) Filho, J. F. A.; Lemos, B. C.; de Souza, A. S.; Pinheiro, S.; Greco,
S. J. Multicomponent Mannich reactions: General aspects, method-
ologies and applications. Tetrahedron 2017, 73, 6977−7004.
(4) Roman, G. Mannich bases in medicinal chemistry and drug
design. Eur. J. Med. Chem. 2015, 89, 743−816.
a
(5) Pati, H. N.; Das, U.; Ramirez-Erosa, I. J.; Dunlop, D. M.; Hickie,
R. A.; Dimmock, J. R. α-Substituted 1-Aryl-3-dimethylaminopropa-
none Hydrochlorides: Potent Cytotoxins towards Human WiDr
Colon Cancer Cells. Chem. Pharm. Bull. 2007, 55, 511−515.
(6) Bala, S.; Sharma, N.; Kajal, A.; Kamboj, S.; Saini, V. Mannich
bases: an important pharmacophore in present scenario. Int. J. Med.
Chem. 2014, 2014, 191072.
Scheme 3. Other Synthetic Transformations of E-6
(8) Rettig, M. B.; Jung, M. E.; Ralalage, D. E.; An, J. Inhibitors of the
N-terminal Domain of the Androgen Receptor (PCT/US2018/
014516). PCT/US2018/014516, 01/19/2018, 2018.
(9) Elshan, N. G. R. D.; Rettig, M. B.; Jung, M. E. Cover Image,
Volume 39, Issue 1. Med. Res. Rev. 2019, 39, i−i.
(10) Elshan, N. G. R. D.; Rettig, M. B.; Jung, M. E. Molecules
targeting the androgen receptor (AR) signaling axis beyond the AR-
Ligand binding domain. Med. Res. Rev. 2019, 39, 910−960.
(11) Campi, E.; Fitzmaurice, N. J.; Jackson, W. R.; Perlmutter, P.;
Smallridge, A. J. A Two-Step Hydroformylation of Alkynes. Synthesis
1987, 1987, 1032−1034.
a
(a) BnSH, DCM 23 °C, overnight, 85%; (b) benzamidinium
chloride, EtOH/H2O, Et3N, reflux, 30 min, 6%.
In summary, through this work we have established, for the
first time, a method to reliably obtain β-amino diaryldienone
compounds of structure 6 (and 3) in excellent stereochemical
(E/Z) purity. In the course of our studies, we have provided
insights into the reaction mechanism, unveiled possible side
reactions, studied the NMR characteristics versus the stereo-
chemistry of the diaryl-substituted enone, and corrected an
erroneously reported structure in current literature.
D
Org. Lett. XXXX, XXX, XXX−XXX